The acquisition of LactoSens® by Kerry Group reflects DirectSens' success in developing cutting-edge biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes.
As an indispensable analytical tool, LactoSens® will work alongside Kerry Group’s ingredient solutions, enabling a more integrated offering for food manufacturers. Kerry Group is a world leader in taste and nutrition, serving the food, beverage, and pharmaceutical markets.
The BRANDL TALOS team advising DirectSens was led by Roman Rericha and Stephan Strass and further supported by Daniel Habich, and Kevin Bley. i5 Invest (Herwig Springer, Stefan Podany) acted as exclusive financial advisor to DirectSens in this transaction.
Kerry Group has been represented by Wolf Theiss (Horst Ebhardt, Hartwig Kienast, Roland Marko, Lisa Bernsteiner).